The Invisible-in-the-canal (IIC) Hearing Aids market is segmented by Application into medical and consumer categories. The medical application constitutes the dominant portion of the market, driven by demand from audiologists, otolaryngologists, and hospitals for prescription-based devices. This segment prioritizes clinical efficacy, regulatory compliance, and integration with diagnostic tools, contributing to ~65% of the market. Conversely, the consumer application segment is expanding due to over-the-counter (OTC) availability and self-purchase trends, particularly among individuals with mild to moderate hearing loss. This segment emphasizes affordability, user-friendly design, and direct-to-consumer marketing, accounting for ~35% of the market. Together, these applications define the IIC Hearing Aids segmentation by end-use, reflecting divergent growth drivers and market dynamics.